Trial
NCT01597596
A Noninferiority Study of Alglucosidase Alfa Manufactured at the 160 L and 4000 L Scales in Treatment Naïve Patients With Infantile-Onset Pompe Disease
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Genzyme, a Sanofi Company
Collaborators
—
Condition
Pompe Disease (Infantile-Onset)
Intervention
alglucosidase alfa
Why stopped
Study was stopped due to approved label expansion of alglucosidase alfa.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-01-18